Purple Biotech Ltd. (PPBT) stock
PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.71+0.03 (+1.79%)
Close on Nov 17, 2026Market cap $1.59MP/E 0.0Yield –
Purple Biotech operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$5.66M. The highest annual figure on record is $1.71M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.66M | – |
| FY2024 | Dec 31, 2024 | -$14.37M | – |
| FY2023 | Dec 31, 2023 | -$19.93M | – |
| FY2022 | Dec 31, 2022 | -$16.74M | – |
| FY2021 | Dec 31, 2021 | -$374.00K | -121.9% |
| FY2020 | Dec 31, 2020 | $1.71M | – |
| FY2019 | Dec 31, 2019 | -$1.97M | – |
| FY2018 | Dec 31, 2018 | -$8.48M | – |
| FY2017 | Dec 31, 2017 | -$8.63M | – |
| FY2016 | Dec 31, 2016 | -$6.26M | – |
| FY2015 | Dec 31, 2015 | -$3.31M | – |
See a number that looks wrong?